Pfizer Inc is > 10% Shareholder of Cortexyme, Inc.. Currently has a direct ownership of 2.88 Million shares of CRTX, which is worth approximately $3.72 Million. The most recent transaction as insider was on Jun 03, 2020, when has been sold 370,000 shares (Common Stock) at a price of $40.18 per share, resulting in proceeds of $14,866,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.88M
0% 3M change
0% 12M change
Total Value Held $3.72 Million

PFIZER INC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2020
SELL
Open market or private sale
$14,866,600 $40.18 p/Share
370,000 Reduced 11.38%
2,879,973 Common Stock
May 13 2019
BUY
Conversion of derivative security
-
3,199,973 Added 50.0%
3,199,973 Common Stock
May 13 2019
BUY
Open market or private purchase
$850,000 $17.0 p/Share
50,000 Added 1.52%
3,249,973 Common Stock

Also insider at

VTRS
Viatris Inc Healthcare
CERE
Cerevel Therapeutics Holdings, Inc. Healthcare
ICUI
ICU MEDICAL INC Healthcare
ALLO
Allogene Therapeutics, Inc. Healthcare
SWTX
SpringWorks Therapeutics, Inc. Healthcare
BCAB
BioAtla, Inc. Healthcare
PYXS
Pyxis Oncology, Inc. Healthcare
IMRA
IMARA Inc. Healthcare
PI

Pfizer Inc

> 10% Shareholder
New York, NY

Track Institutional and Insider Activities on CRTX

Follow Cortexyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRTX shares.

Notify only if

Insider Trading

Get notified when an Cortexyme, Inc. insider buys or sells CRTX shares.

Notify only if

News

Receive news related to Cortexyme, Inc.

Track Activities on CRTX